Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018

Published:2020-03 Issue: Volume:175 Page:104718
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Takashita Emi,Daniels Rod S.,Fujisaki Seiichiro,Gregory Vicki,Gubareva Larisa V.,Huang Weiijuan,Hurt Aeron C.,Lackenby Angie,Nguyen Ha T.,Pereyaslov Dmitriy,Roe Merryn,Samaan Magdi,Subbarao Kanta,Tse Herman,Wang Dayan,Yen Hui-Ling,Zhang Wenqing,Meijer Adam

Funder

Advanced Molecular Detection (AMD) Program

CDC

National Key Research and Development Program of China

Cancer Research UK

Medical Research Council

Wellcome Trust

Ministry of Health, Labour and Welfare, Japan

JSPS KAKENHI

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference24 articles.

1. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus;Abed;J. Infect. Dis.,2009

2. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y;Burnham;Antimicrob. Agents Chemother.,2014

3. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs;Fujisaki;Biochem. Biophys. Res. Commun.,2012

4. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016;Gubareva;Antivir. Res.,2017

5. Baloxavir and treatment-emergent resistance: public Health insights and next steps;Gubareva;J. Infect. Dis.,2020

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant;International Journal of Antimicrobial Agents;2024-09

2. Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in Japan;Antiviral Research;2024-09

3. High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro;Antiviral Research;2024-09

4. Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas;Drug, Healthcare and Patient Safety;2024-09

5. Whole-Genome Analysis of the Influenza A(H1N1)pdm09 Viruses Isolated from Influenza-like Illness Outpatients in Myanmar and Community-Acquired Oseltamivir-Resistant Strains Present from 2015 to 2019;Viruses;2024-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3